8.11.2023
XO Life among the leading startups in the European digital health market
According to the AlbionVC report, XO Life is one of the leading startups in the European digital health market
Financing of healthcare technologies in Europe has once again reached historic levels, with artificial intelligence driving a new wave of growth in digital care and digital pharmacy. AlbionVC is now presenting the new report on the European healthtech market, which includes 998 companies from the digital pharmaceutical and digital care sectors. The card focuses on companies that were founded in 2015 or later, have received institutional funding in the last three years and employ more than 10 people. XO Life is one of the leading companies in its sector.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
Glenmark launcht eigenen Bereich für Malaria-Prophylaxe und -Therapie auf der ImpactMonitor™-Plattform von XO Life
Glenmark und XO Life bieten Patienten digitalen Support auf der ImpactMonitor™ Plattform an.
Dr. Gustav Klein and XO Life: Digital therapy support for users of Gastritol® Liquid for gastrointestinal complaints
Gastritol® Liquid now offers digital therapy support via XO Life's ImpactMonitor™ platform.
XO Life receives 7 Million Euros for the international expansion of its health platform as an alternative to Google, Facebook and Co.
XO Life secures €7 million for global expansion of its ImpactMonitor™ platform, a meta-platform for digital patient support.